Spinocerebellar ataxia type 37 is a rare inherited brain disorder that affects balance, coordination, and speech. Early symptoms of Spinocerebellar ataxia type 37 often begin in adulthood, and many people first notice an unsteady walk or slurred speech. Spinocerebellar ataxia type 37 usually progresses over years, so daily tasks like walking, writing, or speaking clearly can become harder with time. Not everyone will have the same experience, and life expectancy can vary depending on severity, falls, swallowing problems, and overall health. There is no cure, but treatment often includes physical therapy, speech therapy, mobility aids, and supportive care to help people living with Spinocerebellar ataxia type 37 stay as independent and safe as possible.
How many people live with Spinocerebellar ataxia type 37?
Worldwide and U.S. prevalence estimates for spinocerebellar ataxia type 37 are not consistently reported by a single authoritative source. Major rare-disease references such as Orphanet and the NIH Genetic and Rare Diseases Information Center describe it as extremely rare, with only a small number of families reported worldwide and no reliable separate estimate for the United States.
Overview
Spinocerebellar ataxia type 37Symptoms
Spinocerebellar ataxia type 37 usually causes slowly worsening balance and walking problems. Many people also develop slurred speech and shaky, unsteady hand movements. Early symptoms of Spinocerebellar ataxia type 37 can include dizziness or trouble with coordination.
Outlook and prognosis
Spinocerebellar ataxia type 37 usually progresses slowly over years. Many people first notice balance, speech, and eye movement changes, then may need walking aids later on. Lifespan is often near typical, though severity varies.
Causes and risk factors
Spinocerebellar ataxia type 37 is caused by a harmful inherited DNA change, though it can start with a new change in a family. Risk is highest with an affected parent. Age and other genes may influence when symptoms begin.
Genetic influences
Genetics are central to Spinocerebellar ataxia type 37, because it is caused by an inherited DNA change. This usually runs in families in an autosomal dominant pattern, so each child of an affected parent has a 1 in 2, or 50%, chance.
Diagnosis
Doctors usually suspect Spinocerebellar ataxia type 37 from symptoms, family history, and exam findings. The diagnosis of Spinocerebellar ataxia type 37 is confirmed with genetic testing. Brain imaging may help support the diagnosis.
Treatment and drugs
Treatment for spinocerebellar ataxia type 37 focuses on easing symptoms and preserving independence. Physical, occupational, and speech therapy can help with balance, walking, hand use, and swallowing. Many living with spinocerebellar ataxia type 37 also use medicines for tremor, stiffness, mood, or sleep.
Symptoms
Many living with Spinocerebellar ataxia type 37 first notice changes in balance and coordination that can make walking, speaking, or fine hand tasks feel less smooth. Early features of Spinocerebellar ataxia type 37 can include an unsteady gait and a reduced sense of smell, while other changes may appear gradually over time. These changes vary from person to person and can shift as the condition progresses.
Walking can become unsteady, with veering, wobbling, or feeling less secure on turns. Some people with Spinocerebellar ataxia type 37 widen their stance or hold railings more often to feel steady.
Hand and arm movements can lose precision, making buttons, handwriting, typing, or using utensils harder. Leg movements can also become less accurate, which may add to clumsiness when stepping around obstacles.
Speech may sound slow, slurred, or less clear because the muscles used for speaking are not coordinating smoothly. People may need to slow down, pause more, or repeat themselves to be understood.
Some may find that swallowing becomes less smooth, with coughing or throat clearing during meals. Eating can take longer, and it is important to get medical advice if food or drinks seem to go down the wrong way.
How people usually first notice Spinocerebellar ataxia type 37?
People usually first notice spinocerebellar ataxia type 37 as a gradual change in balance and coordination: you may start stumbling more often, walking less steadily, or feeling clumsy with tasks that used to be easy. For many living with this condition, the first signs of spinocerebellar ataxia type 37 can also include slurred speech, unusual eye movements, or shaky, less precise hand movements, and these changes often build slowly rather than appearing all at once. Because the early symptoms can seem subtle at first, many people do not realize right away that they reflect a neurologic condition, but a pattern of worsening unsteadiness over time is often what leads to medical evaluation.
Types of Spinocerebellar ataxia type 37
No distinct types of Spinocerebellar ataxia type 37 are widely recognized.
Can I slow down the onset of symptoms?
At this time, there is no good evidence that lifestyle changes or medical treatment can meaningfully delay the start of symptoms in spinocerebellar ataxia type 37. Because this is caused by an inherited gene change, healthy habits such as staying active, sleeping well, not smoking, and managing blood pressure and other heart-health risks may support overall health, but they have not been shown to prevent the condition or reliably push symptoms back. There is also no proven preventive medicine yet, but regular follow-up with a nerve specialist and genetics specialist can help with planning, support, and access to research as it develops.
What genetics can tell you about symptoms
In spinocerebellar ataxia type 37, the main genetic finding can confirm the diagnosis and helps explain why balance and coordination problems, slurred speech, and eye movement changes tend to happen, although the exact mix of symptoms can still vary from one person to another, even within the same family. In many living with SCA37, a larger repeat expansion is linked with symptoms starting earlier, and it may sometimes go along with a more severe course, but genetics cannot reliably predict exactly which symptoms someone will have or how quickly they will change.
Causes and risk factors
In spinocerebellar ataxia type 37, the main cause is a change in the DAB1 gene. This usually involves an extra repeated piece of DNA, and it is often passed down from a parent. If there is a family history of spinocerebellar ataxia type 37, each child of an affected parent has a 50% chance of inheriting the change. The gene change is the main driver, but age and other genes can affect when symptoms begin and how quickly they worsen. Lifestyle and environment are not known to cause spinocerebellar ataxia type 37, though alcohol and some medicines can make balance or speech problems more noticeable, and researchers are still learning how these pieces fit together.
What are the most common causes or risk factors?
Spinocerebellar ataxia type 37 is mainly caused by an inherited change in a gene called DAB1, so the biggest risk factor is having a parent or other close family member with the condition. It usually runs in families in a dominant pattern, which means each child of an affected parent has a 1 in 2 chance of inheriting the changed gene. There are no well-proven lifestyle, diet, or environmental causes, although symptoms often start later in adult life.
Environmental and biological risk factors
When people look for environmental and biological risk factors for spinocerebellar ataxia type 37, current research offers a fairly clear answer. Doctors often group risks into internal (biological) and external (environmental). So far, no well-established non-genetic biological factors or outside exposures have been shown to increase the likelihood of this condition. Because of that, there are no confirmed environmental or biological risk factors to list here.
Genetic risk factors
Trouble with balance, walking, or speech in spinocerebellar ataxia type 37 usually comes from one inherited DNA change. The main genetic cause is an expanded repeat linked to the DAB1 gene. Carrying a genetic change doesn’t guarantee the condition will appear at the same age or with the same severity in everyone, but family history is a strong clue. Risk is highest when the change is already known in a parent or other blood relative.
DAB1 repeat: Spinocerebellar ataxia type 37 is caused by an abnormal expansion of a short DNA repeat linked to the DAB1 gene. Even though this change is in a non-coding part of DNA, it can still disrupt nerve cells involved in balance and coordination.
Dominant inheritance: SCA37 usually follows an autosomal dominant inheritance pattern, which means one altered copy is enough to cause risk. If a parent carries the expansion, each child has a 1 in 2, or 50%, chance of inheriting it.
Family history: Having close relatives with SCA37 makes it more likely that the same gene change runs in the family. This is often why genetic testing is considered when early symptoms of spinocerebellar ataxia type 37 appear in more than one relative.
Iberian ancestry: SCA37 has been reported most often in families with roots in Spain and Portugal. This seems to reflect a shared ancestral genetic change in some family lines, not anything someone did or did not do.
Repeat size: In some families, a larger repeat expansion may be linked to symptoms starting earlier. Even so, repeat length does not predict the exact course or severity for any one person.
Lifestyle risk factors
Spinocerebellar ataxia type 37 is an inherited neurologic disorder, so lifestyle habits do not cause it. However, how lifestyle affects Spinocerebellar ataxia type 37 can be important for balance, swallowing, communication, mobility, and day-to-day safety as symptoms progress. The most relevant lifestyle risk factors for Spinocerebellar ataxia type 37 are those that can worsen falls, fatigue, poor nutrition, breathing problems, or loss of physical function. Supportive habits may help preserve independence and reduce complications.
Too little regular movement can speed loss of strength, flexibility, balance, and walking ability in people with Spinocerebellar ataxia type 37. Consistent, supervised exercise and physical therapy may help maintain mobility and reduce deconditioning.
Alcohol can further impair coordination, speech, eye movements, and gait, which may intensify ataxia symptoms in Spinocerebellar ataxia type 37. It can also increase fall risk and make daily activities less safe.
Inadequate calorie and protein intake can worsen weakness, frailty, and fatigue, especially if swallowing becomes difficult. When Spinocerebellar ataxia type 37 affects eating, careful meal planning and texture changes may help prevent weight loss.
Rushing meals, taking large bites, or eating without attention to posture can raise the risk of choking or aspiration if swallowing is impaired. Safer eating strategies may lower the chance of chest infections and mealtime distress.
Risk prevention
Spinocerebellar ataxia type 37 cannot usually be prevented if you carry the gene change that causes it, but there is a lot people can do to lower the risk of complications and protect day-to-day function. Prevention is flexible—it adapts to your life and health background. For many living with spinocerebellar ataxia type 37, this means focusing on falls, swallowing problems, weight loss, and staying as active and independent as possible.
If spinocerebellar ataxia type 37 runs in your family, genetic counseling can help you understand your own risk and family planning options. It can also help relatives decide whether testing would be useful before symptoms begin.
Balance problems can make everyday moments risky, like turning quickly in the kitchen or stepping off a curb. Clear walkways, good lighting, handrails, and supportive shoes can lower the chance of falls and injuries.
Regular therapy and home exercises can help maintain strength, balance, and safe walking for as long as possible. Many people with spinocerebellar ataxia type 37 also benefit from mobility aids early, before repeated falls lead to setbacks.
Changes in speech or swallowing should be checked early, even if they seem mild at first. Early symptoms of spinocerebellar ataxia type 37 can include slurred speech and choking on food or liquids, and therapy may help reduce aspiration and weight loss.
Can you prevent Spinocerebellar ataxia type 37?
No, there is currently no proven way to prevent spinocerebellar ataxia type 37, because it is an inherited condition passed down through families. If it runs in your family, meeting with a genetics specialist can help you understand your risk and talk through testing or family planning options, but it cannot stop the condition in someone who has inherited it.
Transmission
Spinocerebellar ataxia type 37 is not infectious, so it cannot be caught from another person through touch, air, sex, food, or blood. Instead, the genetic transmission of Spinocerebellar ataxia type 37 usually happens within families, most often when a parent carries the gene change and passes it to a child.
Many living with Spinocerebellar ataxia type 37 have an affected parent, and each child of a parent who carries the change has a 50% chance of inheriting it. In some families, though, the condition may appear for the first time because of a new genetic change.
When to test your genes
Consider genetic testing for SCA37 if you or close relatives have unexplained, gradually worsening balance problems, slurred speech, or coordination trouble, especially when several family members across generations are affected. Testing can confirm the cause, guide neurologic follow-up, and inform family planning for at-risk relatives.
Diagnosis
Spinocerebellar ataxia type 37 is usually suspected when balance, speech, and coordination problems develop slowly over time, especially if similar symptoms have affected relatives. Doctors usually begin with a careful review of symptoms, a neurologic exam, and family history, because the pattern often gives the first clue. The genetic diagnosis of Spinocerebellar ataxia type 37 is then confirmed with specific testing.
The doctor asks when walking, balance, speech, or hand coordination changes began and how they have progressed. They also look for related problems such as abnormal eye movements, tremor, or swallowing trouble, which can help show whether Spinocerebellar ataxia type 37 is likely.
A neurologic exam checks gait, reflexes, eye movements, strength, and coordination. These findings help show whether the cerebellum and related nerve pathways are affected in the pattern expected for Spinocerebellar ataxia type 37.
Because this condition can run in families, the doctor will often ask whether relatives had balance problems, falls, slurred speech, or an undiagnosed neurologic illness. A detailed family and health history can help point toward an inherited ataxia rather than a non-genetic cause.
A blood test can look for the specific genetic change linked to Spinocerebellar ataxia type 37. This is the main way to confirm the diagnosis of Spinocerebellar ataxia type 37, especially when symptoms and family history fit.
How is Spinocerebellar ataxia type 37 diagnosed?
Spinocerebellar ataxia type 37 is usually diagnosed when a doctor looks at the pattern of symptoms over time, asks about family history, and checks balance, walking, coordination, speech, and eye movements during an exam. A brain MRI may also be done to look for changes in the part of the brain that helps control balance and movement. Genetic testing can then confirm the diagnosis by finding the specific inherited change linked to this condition.
Stages of Spinocerebellar ataxia type 37
Spinocerebellar ataxia type 37 does not have defined progression stages. This is because it usually develops gradually over time, but the pace and pattern can differ a lot from one person to another rather than following fixed steps. Doctors usually start with a conversation about balance, speech, walking, and other early symptoms of spinocerebellar ataxia type 37, then combine that with a neurological exam and often brain imaging. Genetic testing is usually used to confirm the diagnosis, and follow-up visits help track changes in movement, swallowing, speech, and day-to-day function.
Outlook and prognosis
The outlook for spinocerebellar ataxia type 37 is one of slow, progressive worsening over many years, with increasing problems in balance, walking, speech, and coordination that can eventually limit independence. Age at onset and rate of progression vary between individuals and families, but many affected people remain ambulatory for a substantial period before needing walking aids or wheelchair support later in the disease course. Cognitive function is often relatively preserved, although some people may develop additional neurologic or non-motor symptoms that add to disability. Life expectancy is not well defined in the medical literature for spinocerebellar ataxia type 37 specifically, and the disorder is not usually considered rapidly fatal, but advanced disease can increase the risk of complications such as falls, aspiration, and infections. Prognosis is generally shaped by symptom severity, the pace of progression, and access to supportive care such as physical therapy, speech therapy, and swallowing management. Because it is a lifelong neurodegenerative condition, long-term follow-up is important to address changing needs and maintain quality of life as much as possible.
Long-term effects
Many living with spinocerebellar ataxia type 37 find that everyday movements slowly take more effort, from walking across a room to speaking clearly in a noisy place. This condition usually changes over years rather than days, and the pace can differ from one person to another. It’s important to remember that long-term doesn’t always mean progressive in a straight line, because some stretches may feel fairly stable while others bring more noticeable change.
Trouble with balance and coordination often becomes more noticeable over time, which can make walking less steady and increase the risk of falls. Many people begin with early symptoms of spinocerebellar ataxia type 37 such as subtle unsteadiness, then later need more support for stairs, uneven ground, or longer distances.
Speech may become slower, less clear, or more effortful as the muscles used for speaking lose fine coordination. For many, this can mean needing extra time to finish a sentence or repeat words so others can understand.
Some people with spinocerebellar ataxia type 37 develop swallowing problems, especially with thin liquids or mixed-texture foods. Over time, this can raise the chance of choking episodes, weight loss, or food going down the wrong way into the lungs.
Hand movements can become less precise, making tasks like buttoning clothes, using utensils, or typing harder than before. Shaking, clumsiness, and slower reaction time may add to the loss of independence in daily routines.
How is it to live with Spinocerebellar ataxia type 37?
Living with spinocerebellar ataxia type 37 often means adapting to changes that gradually affect balance, walking, speech, and coordination, so everyday tasks like climbing stairs, writing, driving, or speaking clearly may take more effort over time. Many people with SCA37 also notice unsteady movements or tremor-like symptoms, and for some this can lead to a greater risk of falls and a growing need for mobility aids, speech support, or help with daily routines. The effects ripple outward too: family members and other close supporters may take on more practical caregiving, transportation, and emotional support, while also adjusting home, work, and social plans, but with rehabilitation, safety planning, and strong support, many people continue to build meaningful routines and stay connected to the people around them.
Treatment and drugs
Treatment for Spinocerebellar ataxia type 37 focuses on easing symptoms and helping people stay as active, safe, and independent as possible, because there is currently no treatment that can stop or reverse the condition itself. Care often includes physical therapy for balance and walking, speech therapy if speaking or swallowing becomes harder, and occupational therapy for daily tasks such as dressing, writing, or using the kitchen safely. Treatment plans often combine several approaches, and some people with Spinocerebellar ataxia type 37 may also be offered medicines to help with muscle stiffness, tremor, sleep problems, low mood, or dizziness, depending on their symptoms. For many, this can mean using a cane, walker, or home safety changes to reduce falls, especially as early symptoms of Spinocerebellar ataxia type 37 begin to affect day-to-day life.
Can you cure Spinocerebellar ataxia type 37?
No, there is no cure for spinocerebellar ataxia type 37 at this time. Treatment cannot reverse the condition, but it can help manage day-to-day problems and support independence, often through physical therapy, speech therapy, walking aids, and medicines for certain symptoms when needed. Researchers are studying new treatments, but none has yet been shown to cure or stop this condition.
Non-drug treatment
Daily life with Spinocerebellar ataxia type 37 often becomes harder because balance, walking, speech, and coordination gradually change. In Spinocerebellar ataxia type 37, non-drug care focuses on staying safe, keeping as much independence as possible, and making eating and communication easier. Managing this condition often means working with rehabilitation specialists over time, because needs can shift as symptoms change.
Physical therapy can help people with Spinocerebellar ataxia type 37 practice balance, walking, transfers, and leg strength in a safe way. This may lower fall risk and help with everyday tasks like getting up from a chair or turning in a hallway.
Occupational therapy focuses on practical skills such as dressing, bathing, writing, cooking, and using the bathroom more safely. Some strategies can slip naturally into your routine—like changing home setup, using grab bars, or choosing easier-to-hold tools.
Speech therapy can help if speech becomes slow, slurred, or harder for others to understand. Therapies like speech exercises, pacing strategies, or communication devices often make conversations less tiring and more effective.
A speech-language specialist can also check for swallowing problems, which may cause coughing during meals or food feeling stuck. This can be especially helpful when early symptoms of Spinocerebellar ataxia type 37 start to affect eating, because changes in posture, food texture, and bite size may reduce choking risk.
Your genes may have an impact on how drugs work for you
For people living with spinocerebellar ataxia type 37, there is not yet strong, widely accepted proof that the inherited change causing the condition clearly changes how the medicines commonly used for symptoms will work. In day-to-day care, doctors usually choose treatments based on the main problems a person has, such as balance trouble, shaking, muscle stiffness, dizziness, or mood symptoms, and how well those medicines help can vary from one person to another. For many, this means finding the best medication is still a matter of careful trial, dose changes, and watching for side effects, rather than using a genetic test to predict the response.
Pharmacological treatments
Medication for spinocerebellar ataxia type 37 is mainly used to ease symptoms, since there is no drug proven to stop or reverse the condition itself. Many living with spinocerebellar ataxia type 37 need treatment tailored to what affects daily life most, such as walking, muscle stiffness, tremor, mood, or sleep. Not everyone responds to the same medication in the same way. In practice, medications for spinocerebellar ataxia type 37 are usually combined with physical, speech, and swallowing support.
There is no approved medicine that cures spinocerebellar ataxia type 37 or clearly slows its progression. Treatment usually focuses on improving comfort, safety, and day-to-day function.
Riluzole is sometimes used off-label to help cerebellar symptoms such as unsteady walking or slurred speech, although benefit can be modest. In some centers, amantadine or buspirone may also be tried for ataxia symptoms, but results are variable.
If tremor is troublesome, doctors may consider propranolol or primidone. These medicines do not work for everyone, but they can make tasks like eating or writing a bit easier for some people with spinocerebellar ataxia type 37.
Baclofen or tizanidine may help if muscle stiffness, tightness, or spasms are making walking harder. Dosing may be increased or lowered gradually to balance symptom relief with side effects such as sleepiness or weakness.
Genetic influences
Balance trouble, slurred speech, or shaky eye movements showing up in several relatives can be a clue that spinocerebellar ataxia type 37 has a strong inherited basis. It’s natural to ask whether family history plays a role. Spinocerebellar ataxia type 37 is caused by an unusual repeat expansion in the DAB1 gene, meaning a short stretch of DNA is repeated far more times than it should be. It is usually inherited in an autosomal dominant pattern, so one altered copy can cause the condition and each child of a parent with the gene change has a 50% chance of inheriting it. Many living with spinocerebellar ataxia type 37 notice that symptoms start at different ages and progress differently from one family member to another, even though the underlying genetic cause is the same. A genetic test can confirm the diagnosis and help relatives understand their own risk.
Is Spinocerebellar ataxia type 37 genetic?
Genetics are central to Spinocerebellar ataxia type 37, because it is caused by an inherited DNA change. This usually runs in families in an autosomal dominant pattern, so each child of an affected parent has a 1 in 2, or 50%, chance.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of being human and are found commonly across the general population. Most of these variants do not have a direct impact on health and are simply part of normal human variation. In many genes, carrying a variant tied to a condition suggests a possible connection rather than a certain diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well-studied variant in a particular gene can be enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with spinocerebellar ataxia type 37, treatment is mostly about easing day-to-day problems like unsteady walking, speech changes, or dizziness rather than curing the condition. Because spinocerebellar ataxia type 37 is caused by a specific inherited gene change, genetic testing can confirm the diagnosis and help doctors avoid treatments aimed at other causes of ataxia that are unlikely to help. There is currently no approved medicine that fixes the underlying genetic change, so treatment for spinocerebellar ataxia type 37 usually centers on rehabilitation, speech support, and medicines chosen for symptoms if needed. Unlike some other conditions, there are no widely used gene-based rules for choosing specific drugs for spinocerebellar ataxia type 37 symptoms at this time. Not every difference in response is genetic, but inherited differences can sometimes affect side effects or how well symptom medicines work, so doses may need to be adjusted carefully. Knowing the genetic cause can also help families understand recurrence risk and may give access to research studies testing future gene-based treatments.
Interactions with other conditions
Spinocerebellar ataxia type 37 can have a bigger day-to-day impact when it occurs alongside other neurologic or general health problems. Balance trouble, slurred speech, and shaky movements may become harder to manage if someone also has nerve damage, muscle weakness, vision problems, or hearing loss from another condition, since these can add to the difficulty with walking, communication, and daily tasks. Doctors call it a “comorbidity” when two conditions occur together. For many living with spinocerebellar ataxia type 37, depression, anxiety, sleep problems, or swallowing difficulties can also affect quality of life and may make the condition feel more disabling than the movement symptoms alone. Some medicines used for dizziness, sleep, mood, or pain can worsen drowsiness or unsteadiness, so treatment choices often need to be coordinated carefully. If you are wondering about the early symptoms of spinocerebellar ataxia type 37, or whether another illness is making them worse, it is worth discussing this with your care team so they can look at the full picture.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Spinocerebellar ataxia type 37?
Other inherited balance disorders, especially other spinocerebellar ataxias, can look very similar to spinocerebellar ataxia type 37 because they also cause slowly worsening unsteadiness, poor coordination, and speech changes. Doctors may also consider other causes of ataxia, such as multiple system atrophy, multiple sclerosis, stroke, side effects from certain medicines, long-term alcohol use, and low levels of vitamins like B12 or vitamin E. Some of these causes are treatable, so testing is important when symptoms first appear.
History
People living with spinocerebellar ataxia type 37 often notice changes that slowly affect everyday routines, such as needing to hold a railing on stairs, speaking a little less clearly, or finding that balance feels less automatic than it once did. This condition belongs to a group of disorders that affect the cerebellum, the part of the brain that helps coordinate movement, and its history is fairly recent compared with some other neurological conditions.
Spinocerebellar ataxia type 37 was recognized after doctors and researchers began noticing similar patterns of symptoms in several affected families, especially in parts of Europe. At first, the condition was identified by the shared clinical picture: slowly worsening problems with balance and coordination, often along with changes in speech and eye movements. As medical science evolved, better brain imaging, more detailed family studies, and modern laboratory methods helped show that this was a distinct form of spinocerebellar ataxia rather than a broader, undefined movement disorder.
Over time, researchers were able to separate spinocerebellar ataxia type 37 from other types that can look similar early on. This mattered because many spinocerebellar ataxias overlap at first, and the early symptoms of spinocerebellar ataxia type 37 can resemble other causes of unsteadiness or slurred speech. Later work confirmed that spinocerebellar ataxia type 37 has an underlying genetic basis, which improved diagnosis and made it easier for families to understand why symptoms may appear across generations.
Today, the history of spinocerebellar ataxia type 37 is still being written. Researchers continue to study how symptoms begin, why severity can differ from one family member to another, and how to improve care. For many, this growing knowledge means a clearer diagnosis, more informed counseling, and a better foundation for future treatments.